Indivior is a Virginia-based pharmaceutical company that develops and commercializes buprenorphine-based prescription drugs for the treatment of opioid disorders.
Business Model:
Revenue: $883M
Employees: 501-1,000
Address: -
City: North Chesterfield
State: VA
Zip: 23234
Country: US
Indivior is a Virginia-based pharmaceutical company that develops and commercializes buprenorphine-based prescription drugs for the treatment of opioid disorders.
Contact Phone:
+18043791090
Contact Email:
Listed Exchange:
London Stock Exchange
IPO Date:
12/31/2014
Ticker Symbol:
INDV
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2021 | Addex Therapeutics | Post-IPO Equity | 0 |
7/2021 | Addex Therapeutics | Post-IPO Equity | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2014 | IPO | - | 12/2014 | IPO | - |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|